|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4709 | |
| A61K 31/506 | |||
| A61K 31/517 | |||
| A61K 31/5377 | |||
| C07K 16/32 | |||
| A61K 39/395 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61K 31/519 | |||
| A61K 31/55 | |||
| A61K 31/4706 |
| (11) | Patento numeris | 3206717 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15784975.3 |
| Europos patento paraiškos padavimo data | 2015-10-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2015/057940 |
| Data | 2015-10-15 |
| (87) | Numeris | WO 2016/059600 |
| Data | 2016-04-21 |
| (30) | Numeris | Data | Šalis |
| 201462065451 P | 2014-10-17 | US | |
| 201462068175 P | 2014-10-24 | US | |
| 201462068945 P | 2014-10-27 | US | |
| 201562118710 P | 2015-02-20 | US |
| (72) |
BORAL, Anthony, US
LI, Fang, US
LI, Nanxin, US
PANTANO, Serafino, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMBINATION OF CERITINIB WITH AN EGFR INHIBITOR |
| COMBINATION OF CERITINIB WITH AN EGFR INHIBITOR |